A detailed history of Vanguard Group Inc transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 1,889,094 shares of TMDX stock, worth $285 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,889,094
Previous 1,865,115 1.29%
Holding current value
$285 Million
Previous $147 Million 5.12%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$70.86 - $89.93 $1.7 Million - $2.16 Million
23,979 Added 1.29%
1,889,094 $140 Million
Q4 2023

Feb 14, 2024

BUY
$36.74 - $81.08 $1.86 Million - $4.11 Million
50,673 Added 2.79%
1,865,115 $147 Million
Q3 2023

Nov 14, 2023

BUY
$53.47 - $96.07 $1.59 Million - $2.86 Million
29,798 Added 1.67%
1,814,442 $99.3 Million
Q2 2023

Aug 14, 2023

BUY
$66.23 - $88.73 $4.4 Million - $5.89 Million
66,388 Added 3.86%
1,784,644 $150 Million
Q1 2023

May 15, 2023

BUY
$53.63 - $82.33 $1.44 Million - $2.21 Million
26,831 Added 1.59%
1,718,256 $130 Million
Q4 2022

Feb 10, 2023

BUY
$39.08 - $64.29 $1.83 Million - $3 Million
46,734 Added 2.84%
1,691,425 $104 Million
Q3 2022

Nov 14, 2022

BUY
$31.56 - $55.75 $6.58 Million - $11.6 Million
208,377 Added 14.51%
1,644,691 $68.7 Million
Q2 2022

Aug 12, 2022

BUY
$20.56 - $32.15 $2.25 Million - $3.52 Million
109,408 Added 8.25%
1,436,314 $45.2 Million
Q1 2022

May 13, 2022

SELL
$12.58 - $26.94 $45,451 - $97,334
-3,613 Reduced 0.27%
1,326,906 $35.7 Million
Q4 2021

Feb 14, 2022

BUY
$19.16 - $32.68 $1.31 Million - $2.23 Million
68,288 Added 5.41%
1,330,519 $25.5 Million
Q3 2021

Nov 12, 2021

BUY
$25.92 - $34.51 $867,101 - $1.15 Million
33,453 Added 2.72%
1,262,231 $41.8 Million
Q2 2021

Aug 13, 2021

BUY
$21.63 - $40.07 $26.6 Million - $49.2 Million
1,228,778 New
1,228,778 $40.8 Million

Others Institutions Holding TMDX

About TransMedics Group, Inc.


  • Ticker TMDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 31,831,400
  • Market Cap $4.79B
  • Description
  • TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...
More about TMDX
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.